Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis

Gastro esophageal reflux (GER) is common in cystic fibrosis (CF) and may contribute to lung disease. Approximately 50% of patients with cystic fibrosis are being treated with proton pump inhibitors (PPIs).